目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Intended Audience
Methodology and Information Sources
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Table Summary : Global Market for mRNA Therapeutics, by Country/Region, Through 2026
Figure Summary : Global Market for mRNA Therapeutics, by Country/Region, 2020-2026

Chapter- 3: Target Diseases and Disorders
Overview of Common Diseases and Disorders for mRNA Therapeutics
Tobacco Smoking and Associated Diseases
Infectious Diseases: COVID-19 Pandemic Set the Stage for mRNA Therapeutics
Chronic Diseases: Expanding Horizon for mRNA Therapeutics
Rare Diseases: Large Unmet Need is Fueling mRNA Therapeutics
Aging, Gender and Onset of Diseases
Current Challenges and Future Directions

Chapter- 4: RNA Therapeutics
RNA Therapeutics Overview
Evolution of RNA Therapeutics
DNA vs. RNA Therapeutics
Clinical Need for RNA Therapeutics
RNA Therapeutics
Manufacturing RNA-Based Biopharmaceuticals
Delivery of RNA Therapeutics
Institution and Hospital-Based RNA Therapeutics
Regulatory Influence on the Market for RNA Therapeutics
Market Situation for RNA Therapeutics
Therapeutics and Cost Burden
Unmet Need
Current Challenges and Future Developments

Chapter- 5: MRNA Vaccines
Vaccines: Overview
Vaccine-Based Disease Prevention
Evolution of mRNA as Vaccine
Clinical Need for mRNA Vaccines
mRNA Vaccines and Types by Application
mRNA Vaccine Product Segments
Immunogenicity and mRNA Vaccines
Formulation and Delivery of mRNA Vaccine
Approaches for Enhancing mRNA Stability
Advantages of mRNA Vaccines
Traditional Vaccine vs. mRNA Vaccines
Marketed/Commercial mRNA Vaccines
mRNA Vaccine Pipeline and New Developments
mRNA Vaccines and Future Pandemics
Unmet Need
Current Challenges and Future Outlook

Chapter- 6: MRNA Drugs and Therapies
Overview of Drugs and Therapeutics
Therapeutic-Based Disease Treatment
Evolution of mRNA: Beyond Vaccines
Clinical Need for mRNA Therapeutics Beyond Vaccines
mRNA Vaccines vs. mRNA Therapeutics
mRNA Therapeutics and Types
Advantages mRNA Drugs and Therapies
Delivery of mRNA Therapeutics
mRNA Therapeutics Pipeline and New Developments
Unmet Need for mRNA Therapeutics
Current Challenges and Future Outlook

Chapter- 7: Market Size and Growth Analysis
Overview
Market Size and Growth Analysis by Region
Market Size and Growth Analysis by Product Segment
Market Size and Growth Analysis by Therapeutic Treatment Type
Market Size and Growth Analysis by Disease Type
Market Growth Drivers and Restraints
Regulatory Impact on the Market for mRNA Therapeutics
SWOT Analysis of the Market for mRNA Therapeutics

Chapter- 8: Competitive Landscape in the Market for mRNA Therapeutics
Disease Prevention and Treatment with mRNA Therapeutics

Chapter- 9: Strategies in the Market for mRNA Therapeutics
Consolidation in the Pharmaceutical Market
Mergers and Acquisitions in the Biopharmaceutical Market
Recent Strategic Moves in mRNA Therapeutics
Future Strategic Landscape

Chapter- 10: Regulatory Structure for Biopharmaceuticals
Regulatory Background
Regulatory Systems for Biopharmaceuticals by Region
Regulatory Systems for Medical Devices by Region
Regulations for mRNA Therapeutics
Key Regulatory Updates, 2020

Chapter- 11: Pricing and Reimbursement: Pharmaceuticals and Biologics
Pricing and Reimbursement Background
Pricing and Reimbursement of Pharmaceuticals and Biologics by Region
Pricing and Reimbursement Challenges for Pharmaceuticals
Pricing and Reimbursement for Medical Devices by Region

Chapter- 12: Conclusions on the Outlook for mRNA Therapeutics
Major Developments Influencing the Market
Long-Term Outlook

Chapter- 13: Company Profiles
ACCURNA INC.
AMGEN INC.
ARCTURUS THERAPEUTICS INC.
ARGOS THERAPEUTICS INC.
ARROWHEAD PHARMACEUTICALS
ATHERSYS
BIOCAD
BIONTECH
BOEHRINGER INGELHEIM
CANSINOBIO
CARTESIAN THERAPEUTICS INC.
CHIMERON BIO
CRISPR THERAPEUTICS INC.
CUREVAC
DAIICHI SANKYO
ELI LILLY AND CO.
ELIXIRGEN THERAPEUTICS INC.
ETHERNA IMMUNOTHERAPIES
ETHRIS GMBH
GENENTECH (SUBSIDIARY OF ROCHE)
GLAXOSMITHKLINE PLC
GREENLIGHT BIOSCIENCES INC.
HDT BIO CORP.
IN-CELL-ART
INTELLIA THERAPEUTICS
IONIS PHARMACEUTICALS INC.
JOHNSON & JOHNSON
KERNAL BIOLOGICS INC.
MAXCYTE INC.
MERCK KGAA
MERCURNA
MODERNA THERAPEUTICS
NOVARTIS
NUTCRACKER THERAPEUTICS
PFIZER
PHION THERAPEUTICS
POSEIDA THERAPEUTICS INC.
QUARK PHARMACEUTICALS
RECODE THERAPEUTICS
REGULUS THERAPEUTICS
RNAIMMUNE INC.
ROCHE
SANGAMO THERAPEUTICS INC.
SANOFI
SAREPTA THERAPEUTICS
SHANGHAI BENDAO GENE TECHNOLOGY CO., LTD.
STEMIRNA THERAPEUTICS LTD.
STRAND THERAPEUTICS
TIBA BIOTECHNOLOGY LLC
TRANSLATE BIO
VERTEX PHARMACEUTICAL

Chapter- 14: Appendix A: List of Acronyms
Table 63 : List of Acronyms Used in the Market for mRNA Therapeutics

Chapter- 15: Appendix B: Professional Organizations
American Heart Association (AHA)
The Bill and Melinda Gates Foundation (BMGF)
Canada's International Development Research Centre (IDRC)
Center for Devices and Radiological Health (CDRH)
Center for Drug Evaluation and Research (CDER)
Centers for Medicare and Medicaid Services (CMS)
The Coalition for Epidemic Preparedness Innovations (CEPI)
Hormone Foundation
International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
National Center for Biotechnology Information (NCBI)
National Institute of Aging (NIA)
Network for Excellence in Health Innovation (NEHI)
Pharmaceuticals and Medical Devices Agency (PMDA)
U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)
U.S. Food and Drug Administration (FDA)
U.S. National Institutes of Health (NIH)
World Cancer Research Fund International
World Health Organization (WHO)